Sensitivity of Immediate and Delayed Gadolinium-Enhanced MRI After Injection of 0.5 M and 1.0 M Gadolinium Chelates for Detecting Multiple Sclerosis Lesions
Ender Uysal1,
Sukru Mehmet Erturk1,
Hakan Yildirim1,
Feray Seleker2 and
Muzaffer Basak1
1 Department of Radiology, Sisli Etfal Hospital, Etfal Sok, Istanbul 80220,
Turkey. 2 Department of Neurology, Sisli Etfal Hospital, Istanbul 80220, Turkey.
Fig. 1A 35-year-old man with multiple sclerosis. Axial fast spin-echo
T2-weighted image (TR/TE, 4,800/102; inversion time, 2 milliseconds) shows
plaque lesion at left side of pons near tectum.
Fig. 1B 35-year-old man with multiple sclerosis. Ten minutes after IV
administration of 0.5-mol/L contrast medium (0.1 mmol/kg), no contrast
enhancement attributable to this lesion is detectable on magnetization
transfer contrast-enhanced T1-weighted image (560/15; inversion time, 1
millisecond).
Fig. 1C 35-year-old man with multiple sclerosis. Immediately after
administration of 1.0-mol/L contrast medium (0.2 mmol/kg), focal contrast
enhancement (arrowhead) is barely detectable.
Fig. 1D 35-year-old man with multiple sclerosis. However, 5 (D) and
10 (E) minutes after administration of 1.0-mol/L contrast medium (0.2
mmol/kg), enhancement is clearly visible in this lesion.
Fig. 1E 35-year-old man with multiple sclerosis. However, 5 (D) and
10 (E) minutes after administration of 1.0-mol/L contrast medium (0.2
mmol/kg), enhancement is clearly visible in this lesion.
Fig. 2A 27-year-old woman with multiple sclerosis (MS). Millimetric MS
plaque lesions are seen in subcortical white matter and at periventricular
region on axial fast spin-echo T2-weighted image.
Fig. 2B 27-year-old woman with multiple sclerosis (MS). Ten minutes after IV
administration of 0.5-mol/L contrast medium (0.1 mmol/kg), no contrast
enhancement attributable to a white matter lesion is detectable on
magnetization transfer contrast-enhanced T1-weighted image.
Fig. 2C 27-year-old woman with multiple sclerosis (MS). Immediately after
administration of 1.0-mol/L contrast medium (0.2 mmol/kg), there is also no
contrast enhancement.
Fig. 2D 27-year-old woman with multiple sclerosis (MS). However, 5
(D) and 10 (E) minutes after administration of 1.0-mol/L
contrast medium (0.2 mmol/kg), one enhancing lesion (arrowhead) is
detectable in frontal left lobe. Note that enhancement is more prominent on
latest image.
Fig. 2E 27-year-old woman with multiple sclerosis (MS). However, 5
(D) and 10 (E) minutes after administration of 1.0-mol/L
contrast medium (0.2 mmol/kg), one enhancing lesion (arrowhead) is
detectable in frontal left lobe. Note that enhancement is more prominent on
latest image.